In collaboration with Natera and Lifelabs, Colorectal Cancer Canada (CCC) hosted an Information Webinar for healthcare professionals regarding the Canadian launch of Signatera™, on February 13th 2023. Signatera™ is a highly sensitive molecular residual disease assay (MRD) using circulating tumor DNA (ctDNA) custom designed for each patient. It will offer ...
Tush Talks is a series that aims to support patients, caregivers and their families with practical information about colorectal cancer diagnosis, treatment, and survivorship. The webinars will occur on a bi-monthly basis and will be led by our Associate Director of Communications, Carl Bindman, alongside a range of guest speakers ...
Colorectal Cancer and Biomarker Testing. What Patients Need to Know. What is the right care for you? There have been considerable advances in the treatment of colorectal cancer over the past 15 years. Certainly, treating colorectal cancer today is different than it was a few decades ago. In the past ...
The following table summarizes the Canadian Association of Gastroenterology's recommendations for colorectal cancer screening among individuals who have immediate family members diagnosed with the disease.
An in-depth guide for people living with colorectal cancer.
1 Westmount Square, Suite 1630
Westmount, QC H3Z 2P9
Canada
info@colorectalcancercanada.com
© Colorectal Cancer Canada All rights reserved
Charitable registration number 86657 2423 RR0001
